Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Blood Advances
|
August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
Vincent Camus, Cédric Rossi, Pierre Sesques, et al.
British Journal of Cancer
|
October 3, 2025
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort
Enrique Almanza-Aguilera, David Guananga-Álvarez, Yolanda Benavente, et al.
Blood Advances
|
May 12, 2026
Prognostic Value of Combined Baseline FDG PET/CT Radiomic Parameters in Primary Mediastinal B-Cell Lymphoma
Pierre Decazes, Cedric Rossi, Pierre Sesques, et al.
Scientific Reports
|
August 16, 2020
Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development
Fatemeh Saberi Hosnijeh, Pieter M Kolijn, Delphine Casabonne, et al.
International Journal of Cancer
|
October 31, 2020
Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis
Fatemeh Saberi Hosnijeh, Delphine Casabonne, Alexandra Nieters, et al.
Environmental Pollution (Barking, Essex : 1987)
|
December 8, 2023
Long-term exposure to ambient air pollution and risk of leukemia and lymphoma in a pooled European cohort
Tahir Taj, Jie Chen, Sophia Rodopoulou, et al.
International Journal of Cancer
|
February 4, 2020
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
Delphine Casabonne, Yolanda Benavente, Julia Seifert, et al.
American Journal of Epidemiology
|
November 28, 2018
Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition
Laura Costas, Leila Lujan-Barroso, Yolanda Benavente, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Blood Advances
|
August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study
Vincent Camus, Cédric Rossi, Pierre Sesques, et al.
British Journal of Cancer
|
October 3, 2025
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort
Enrique Almanza-Aguilera, David Guananga-Álvarez, Yolanda Benavente, et al.
Blood Advances
|
May 12, 2026
Prognostic Value of Combined Baseline FDG PET/CT Radiomic Parameters in Primary Mediastinal B-Cell Lymphoma
Pierre Decazes, Cedric Rossi, Pierre Sesques, et al.
Scientific Reports
|
August 16, 2020
Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development
Fatemeh Saberi Hosnijeh, Pieter M Kolijn, Delphine Casabonne, et al.
International Journal of Cancer
|
October 31, 2020
Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis
Fatemeh Saberi Hosnijeh, Delphine Casabonne, Alexandra Nieters, et al.
Environmental Pollution (Barking, Essex : 1987)
|
December 8, 2023
Long-term exposure to ambient air pollution and risk of leukemia and lymphoma in a pooled European cohort
Tahir Taj, Jie Chen, Sophia Rodopoulou, et al.
International Journal of Cancer
|
February 4, 2020
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
Delphine Casabonne, Yolanda Benavente, Julia Seifert, et al.
American Journal of Epidemiology
|
November 28, 2018
Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition
Laura Costas, Leila Lujan-Barroso, Yolanda Benavente, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 19, 2024
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, et al.
Journal of Hematology & Oncology
|
April 3, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, et al.
Page
of 10